Pharmaceutical Supply for Defence Medical Services

Work Description - NA

This tender, bid number GEM/2026/B/7606346, issued by the Department of Defence, specifically the Organisation Name "Dg Armed Forces Medical Service" under the Ministry of Defence, is for the supply of a diverse range of pharmaceutical products. The bid will commence on August 9, 2026, at 1:00 PM and conclude on August 10, 2026, at 1:00 PM. The contract encompasses a substantial total quantity of 580,315 units of various medicines, including Insulin Humalog, Insulin Premixed Biphasic, Isapgol (Ispaghula husk), Isotretinoin capsules (10mg and 20mg), Ketorolac Tromethamine, L Arginine sachets, Lacosamide tablets (100mg and 200mg), Lamotrigine tablets (100mg, 25mg, and 50mg), Latanoprost eye drops, Leflunomide tablets (10mg and 20mg), Leuprolide Acetate injections (3.75mg), Levetiracetam tablets (250mg and 750mg), Rotacaps containing Ipratropium Bromide and Levosalbutamol, Levosulpiride with Esomeprazole tablets, Lidocaine with Metronidazole preparations, Lithium Carbonate tablets, Loperamide tablets, Lorazepam tablets, Lurasidone tablets, Mebeverine tablets, Megestrol Acetate tablets, Memantine tablets, Mesalamine (1.2gm tablets and 500mg suppositories), Methimazole tablets, and an oral ointment containing Metronidazole, Chlorhexidine, and Lignocaine. This procurement is vital for ensuring the continued healthcare provision and operational readiness of the Armed Forces.